Tyratech Share Discussion Threads

[gemferret] 17/8/2014 22:47

corrintes

Nomads do the work for them. The contact names are listed, and I rang them. When I mentioned product names they hadn't the first clue what I was going on about, and admitted they get very little time to look at companies blah blah blah an know little about them.

PIs can be far more clued up about the inner workings than any analyst or nomad.

If you don't believe that then you haven't the first clue about nomads in the AIM.

I did get a call back from someone in the end, but it was 'um er' to the questions with a 'I'll get the company to speak to you to answer those questions'..... still waiting.

It's not about ripping the company apart, there is an unreported event which may or may not be relevant to their business position. All I want as a potential investor is an answer to the question about, Envance, terminix and the position of Amvac.

For all I know Terminix could be going off shelves for other reasons, but for now the trademark issue and timing seems to be the best bet.

I'm behind on the history side of this company, but fine on the current situation.

On the history what happened to the deal with Arytsa life science ???

I'll have a look.

[captain_kurt] 17/8/2014 22:25

Lol, major institutions like the ones in Blnx and QPP who took up fundraising at a significant premium to the current prices and are down over 70%?

Always dyor.

Tyratech need to tell shareholders the full story concerning Envance.

[gemferret] 17/8/2014 22:23

Deramping ???

Surely that's a defensive load of cobblers from a bull.

The facts are terminix has been disappearing off shelves and I wanted to know why. No one here seems to know a damn thing about it, other than Ga mentioning it.

I asked questions, no one here has answers, which tells me you are either ignorant to the disappearing stock or are just turning a blind eye. So I looked and found that BASF took on Tyratech re the name Envance. As shown, without any doubt whatsoever the trademark name on the US trademark site was withdrawn and is shown as 'killed'.

Then the links to the court case showing termination of proceedings, and obviously because they realised there was no point in a legal battle, as the challenger had a similar name in a similar sector.

Those is called FACTS not deramping.

I bet no one here had the first clue that the trademark name Envance has been abandoned

I assume you are the one that voted Sidam's post up re Amvac paying for all costs, when the annual report suggests otherwise.

Personally I like balanced views and serious fact finding rather than blinkered junk.

I'm all ears and would love to learn that Amvac incur all costs. I'm not saying there isn't something out there that replaces what is in the annual report.

If someone could kindly point to it, I'd appreciate it, it ticks a box.

I like the look of the company, but something was clearly up re Terminix and after a lot of effort I found the problem.

As said I'll be on the phone to the nomad in the morning, as will a few others I suspect.

Eden research will love this event, as they have been saying Tyratech have been cutting corners. The Envance trademark has sod all to do with cutting corners, but Eden won't let the truth spoil a good rumour.

[corrientes] 17/8/2014 21:55

Excellent deramping here. I wonder why two major institutions were each willing to take up 100% of the recent offering ? According to some people here, you might think these II's must be idiots, and wouldn't have bothered to do their homework. Not in a thousand years.

[gemferret] 17/8/2014 20:57

And in the next annual report (2013)

The Company made a $400,000 investment for a 40% share of a new enterprise (Envance Technologies, LLC or Envance) in late 2012, which is jointly owned with AMVAC Chemical Corporation (AMVAC), a wholly owned subsidiary of American
Vanguard Corporation.

[gemferret] 17/8/2014 20:45

Sidam

I'm trying to catch up here. Can you point me to the reference where Amvac take on all costs, because the below suggests they cover 40% of costs.

I'm going on the annual report post deal which says-:

Envance jointly owned by AMVAC (60%) and TyraTech (40%). The company is funded by capital contributions from TyraTech and AMVAC in proportion to their shareholdings.
The parties have made initial capital contributions on this basis totalling $1 million.

So in answer to my own question the other day, it looks like Tyra put $400k into the development of the JV company Envance.

[sidam] 17/8/2014 17:58

GF
If you had done the homework that you said you have, you would know that there is no forecast revenue from Terminix in consensus estimates for Tyratech. The sales are through a JV controlled and financed by AMVAC. It is an associate so no revenue is consolidated by Tyratech.

AMVAC fully finance the JV. So even if you are correct that there are no sales, there is NO COST to Tyratech. Therefore your suggestion that Tyratech will need more money to change its name etc, is COMPLETELY WRONG.

[deepvalueinvestor] 17/8/2014 17:14

Captain, erm, there are a number of good posters on here so you might want to ask them. Gemferret has only just appeared .....

[captain_kurt] 17/8/2014 16:35

Well i was looking to make an initial investment as I like the story here.
But will hold off following gemferrets revelations.

The company has to inform the market, I would say it's material information.

I have emailed the company for an explanation.

[gemferret] 17/8/2014 16:04

A double whammy as they are not getting the forecast revenue re Terminix sales and they will have to spend money on many aspects removing the Envance name.

The name will by on employee contracts to supply deals and so on, we all know it costs money and time for companies on a change their name.

I'm hoping Amvac stay on board but even with a new product name it could be many months before a new name is developed, embedded through all the legal aspects, then applied to the various products etc etc. and then for the product to be on sale. My guess would be next spring before products will re-appear.

Novartis have only just started so a lot of pressure on vamousse which is seasonal, as is guardian and they will miss the boat re that this year.

I seriously consider they will now need some more funding to finance the change of name, and lack of product sales. It's something they hadn't factored in.

[the librarian] 17/8/2014 09:47

Time for guaranteed stop losses? Hope they put out an rns to clarify!

[gemferret] 17/8/2014 09:26

Yes

Then obviously just like the Envance set up money will have to be thrown at it, Tyra are committed to 40% on Envance.

So now they need a new product name, various changes re packaging, so legal work no doubt.

I'm now thinking the Vamousse rapid UK launch is more to do with covering the loss of sales for Terminix, and to cover the period (which could be quite lengthy) re a new product name.

I'll try and find the figures they mention in relation to the costs involved re Envance.

I have sent the company another, not so friendly, email.

It very much explains why PIs are the only buyers and the drifting. The nomad knows and brokers will too, so they will be telling any fund interest to wait and keep PIs in the dark, same old story.

[the librarian] 17/8/2014 07:41

That doesn't look good Gemferret, I don't know what to say about that, it raises so many questions! I suppose the first thought is that Amvac will either be putting pressure on them to trademark a new name and quickly... or bailing?

[zelder] 16/8/2014 22:27

Brooke Bissinger on TV talking about Vamousse and Guardian, with demonstration:

www.wncn.com/video?clipId=10477525&autostart=true

[gemferret] 16/8/2014 20:33

Aha

Right the nomad is going to get some earache Monday morning. I found some details and it looked like either BASF had withdrawn orTyratech had abandoned the trademark.

So I did a bit more digging



The trademark shows as dead as of 26th July 2014 in that link

Live/Dead Indicator DEAD


That's probably the direct reason why the Terminix product is disappearing off shelves.

They did a trademark deal with Terminix, then did a JV with AMVAC to sell through Envance which is now a dead name. simples.

Now I'm happy, I knew something was up, and the 'ums and ers' say it all.

Now FFS Tyratech tell us what is going on re the Envance JV as Amvac own 24% of the shares.

[gemferret] 16/8/2014 19:48

Still some hurdles to be negotiated for me, as below.

I see the regulated shares keep dropping and that will be those on the US side closer to the company

This may be a contributory factor to the apparent sudden cessation of the sale of Terminx through the JV Envance. As you will see below since about April 14 Elevance (looks like it's something to do with the chem giant BASF) has taken action to stop the name Envance becoming a trademark, as below.

Initial request

'This company Elevance Renewable Sciences has filed for the opposition of the trademark name Envance technologies.'

Latest request sent on 24th July

The request to extend time to oppose is granted until
9/14/2014 on behalf of potential opposer BASF Corporation

Please do not hesitate to contact the Trademark Trial and
Appeal Board at [phone] if you have any questions
relating to this extension.


The nomad won't speak, the company won't respond, the Terminix brand product is dropping off shelves, BASF are challenging the trademark, the US regulated share price continues to fall.

I suspect Terminix have pulled the plug due to the legal challenge, as they I'm sure they wouldn't want their name dragged into the trademark issue.

"Um, er, dormant" now speaks volumes.

Hence, I want to know, and believe investors have a right to know, what is going on with Terminix, the JV, and now the Envance name.

Overall it is not an issue but currently the company news and circumstances suggest the Terminix product is within a JV, and actively being sold in the US, which is clearly not the case.

[deepvalueinvestor] 16/8/2014 08:26

Yes Gem, the most money to be made in recent years is through rotating back and forwards between the share classes. A complete no brainer although a bit of a lottery as to which tyr you buy as some converted to tyru last time and some didn't. I dealt through one of the major wealth managers.

[the librarian] 15/8/2014 23:25

Clean and clear harold, they used tea tree oil a one of the main ingredients... can't remember much else about it to be honest but was impressed by the fact that they did it with very little money (some financial backing) and that they were able to get it into Boots.

Tyratech should be able to really promote it with their recent budget and word of mouth will do the rest!

[gemferret] 15/8/2014 19:22

Deep
I assume you have gone for the regulated shares due to the share price Who did you get them through?

Does anyone know where to find the pipeline products, 10 to 15 out there somewhere.

[deepvalueinvestor] 15/8/2014 17:18

Thanks very much. I picked up a cheeky 75k at 7.24p this morning.

[haroldthegreat] 14/8/2014 23:52

librarian what was the name of the product?

[the librarian] 13/8/2014 10:35

Must admit that I have been watching TYR for a while.... since CR announced that no US companies are successful on AIM!

So I looked through them all and TYR stood out to me as one to keep an eye on for the future.

About 15 years back some friends of mine produced a non chemical concoction for head lice treatment and built up the business whilst living in a council house, they outsourced the production of it and focussed on marketing and sales... managed to get it onto the shelves in Boots etc; with just the one person being the sales team :-)

Anyway they sold out of it three years later with £500,000 in their pocket... the possibilities are there for TYR to dominate the market in that area, but they do need to get those other products working for them, so will be interested to see what they are planning.

[gemferret] 13/8/2014 09:09

I agree Nobby. The trouble when shares are tight it frightens off funds, I'm sure the nomad will find somewhere to park them with willing participants.

The lack of obvious Terminix revenue was a concern v the product capability. The fact homedepot and Walmart have the main products out of stock tells you those sold well.
Will Tyra go own brand for that, or will Natunex appear in the consumer section, it's the same product with a different lable.


One concern re nits to me is the cross contamination to surroundings, especially beds. I believe Tyra have plans re that too., which is welcome.

I guess one problem nowadays is those darn sleepovers which is well represented in the US for many years via summer camps.

I think Tyra are doing a great job going via own brands in the consumer section, but I put that down to the management experience.

The mysterious stagnant volumes and SP, I now put down to the circs identified. Funds will not buy on the market if they know there is a pot to pick them up from in bulk at good prices.

Time to keep an eye on 'other trades' that can be high numbers but don't move the price.

In theory if they keep on this route of own products then they will need further funding, but nothing to a level that I consider an issue going forward.

EG they would need more to push Vamousse EU wide and worldwide. The US was the first indicator and results there, have prompted a rapid roll out here.

[nobbygnome] 13/8/2014 08:43

At least gem has provoked a good discussion on this thread! Turnover from the Terminix brands was minimal so it is of little consequence if that deal has come to an end. I am certain the shares will be placed if they do want to dispose of their stake so for me there is nothing to worry about. The future is Vamousse, Guardian and Novartis. They are delivering on all 3!

GLA

Nobby

[gemferret] 13/8/2014 08:39

Doh


I'm guessing no one that has posted here has seen any broker notes.

I've had some recent contact. A recent broker note makes much of the vamousse, guardian and the Novartis deal.

The Amvac Envance JV gets a casual mention at the end. A wishy washy reference, so I suggest things are 'up in the air' re that deal, and our findings are pointing to that deal ending.

That may be why the share price and volume action is down in the doldrums while the brokers and city folk wait for the outcome of what is going on re the JV and Amvac's holding.

Such folk do check the bulletin boards, so they will know that we know.

Get a line drawn under that Tyra (officially) and let's move on.